CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading organization profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

Consejo Superior de Investigaciones Científicas - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Organizations/government

government organization

Consejo Superior de Investigaciones Científicas

ES

OPENALEX: I134820265↗ROR: 02gfc7t72↗

People

Connected researchers

Albert AdellORCID 0000-0003-0570-4931 Ekaterina NoskovaORCID 0000-0002-6696-8773 Guadalupe MengodORCID 0000-0001-7223-7873 Jorge ManzanaresORCID 0000-0002-4681-1533 M. Teresa VilaróORCID 0000-0002-9665-0766 Nadine JagerovicORCID 0000-0003-2642-6969 Pilar Sánchez-BlázquezORCID 0000-0002-7211-4504 Raquel AbaloORCID 0000-0002-6726-8795 Roser CortesORCID 0000-0001-5412-3813 Sergio Montserrat-de la PazORCID 0000-0001-5400-3192 V. RullORCID 0000-0002-9961-105X

Public evidence

5 connected articles

Characterization of the Antitumor Potential of Extracts of <i>Cannabis sativa</i> Strains with High CBD Content in Human Neuroblastoma.2023 · Europe PMC Identification of BiP as a CB<sub>1</sub> Receptor-Interacting Protein That Fine-Tunes Cannabinoid Signaling in the Mouse Brain.2021 · PubMed Central Open Access Cannabidiol and Other Non-Psychoactive Cannabinoids for Prevention and Treatment of Gastrointestinal Disorders: Useful Nutraceuticals?2020 · Europe PMC An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol.2017 · Europe PMC The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: implications in psychosis and schizophrenia2014 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: OpenAlex.